newsfilter
← Latest News
FDA Approved Drugs·

Approval of Cambia, Nda #022165 (Labeling)

Approval Date: 11/21/2024; Drug Name: Cambia, Nda #022165; Active Ingredients: DICLOFENAC POTASSIUM; Company: Assertio; Submission Status: Approval; Submission Classification: Labeling; Application Number: 022165

Company
ASSERTIO
Keywords
ASSERTIO